Variations in — — — — — — — — — — radiotherapy Please provide other factors impacting or management 2. In your practice setting/experience, do you have access to a multidisciplinary team for the TREATMENT of lung cancer? Yes No 3. To what level do you think the following information should be included in clinical guidance material. The lower the number on the scale the lower level of your agreement. Information 1 2 3 4 5 6 7 8 9 10 agree Identification of — — — — — — — — — — specific patient populations at high risk e.g. patients with ongoing symptoms and non specific test results Strategies for — — — — — — — — — — monitoring patients with ongoing symptoms and non specific test results Information — — — — — — — — — — regarding managing comorbidities Information in — — — — — — — — — — determining prognosis Guidance in — — — — — — — — — — determining suitability for surgery and operative risk Evidence based — — — — — — — — — — recommendations for diagnosis [Evidence based — — — — — — — — — — strategies for treatment
Variations in radiotherapy — — — — — — — — — — Please provide other factors impacting or management 2. In your practice setting/experience, do you have access to a multidisciplinary team for the TREATMENT of lung cancer? Yes No 3. To what level do you think the following information should be included in clinical guidance material. The lower the number on the scale the lower level of your agreement. Information 1 2 3 4 5 6 7 8 9 10 agree Identification of specific patient populations at high risk e.g. patients with ongoing symptoms and non specific test results — — — — — — — — — — Strategies for monitoring patients with ongoing symptoms and non specific test results — — — — — — — — — — Information regarding managing comorbidities — — — — — — — — — — Information in determining prognosis — — — — — — — — — — Guidance in determining suitability for surgery and operative risk — — — — — — — — — — Evidence based recommendations for diagnosis — — — — — — — — — — [Evidence based strategies for treatment — — — — — — — — — —